ClinicalTrials.gov record
Terminated Not applicable Interventional Results available

CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery

ClinicalTrials.gov ID: NCT03384875

Public ClinicalTrials.gov record NCT03384875. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 2:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery (REFRESH II Trial)

Study identification

NCT ID
NCT03384875
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
CytoSorbents, Inc
Industry
Enrollment
186 participants

Conditions and interventions

Interventions

  • CytoSorb Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 18, 2018
Primary completion
Jan 17, 2022
Completion
Jan 17, 2022
Last update posted
Dec 3, 2024

2018 – 2022

United States locations

U.S. sites
20
U.S. states
16
U.S. cities
19
Facility City State ZIP Site status
Yale School of Medicine New Haven Connecticut 06510
University of Chicago Chicago Illinois 60637
Indiana University Health Methodist Hospital Indianapolis Indiana 46202
Iowa Heart Center West Des Moines Iowa 50266
University of Louisville Louisville Kentucky 40202
Maine Medical Center Portland Maine 04102
University of Maryland Baltimore Maryland 21201
Brigham and Women's Hospital Boston Massachusetts 02115
Valley Hospital Ridgewood New Jersey 07450
Columbia University Medical Center New York New York 10032
Northwell Health: Lennox Hill Hospital New York New York 10075
Duke University Medical Center Durham North Carolina 27710
East Carolina University Greenville North Carolina 27858
The Christ Hospital Linder Research Center Cincinnati Ohio 45219
Ohio State university Columbus Ohio 43210
Integris Baptist Medical Center Oklahoma City Oklahoma 73112
University of Pennsylvania Philadelphia Pennsylvania 19104
Baptist Memorial Hospital Memphis Tennessee 38120
Vanderbilt University Nashville Tennessee 37212
Baylor College of Medicine Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03384875, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2024 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03384875 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →